Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:106-110
Published online before print October 16, 2008, doi: 10.1161/STROKEAHA.108.525774
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/1/106    most recent
STROKEAHA.108.525774v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiorella, D. J.
Right arrow Articles by McDougall, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiorella, D. J.
Right arrow Articles by McDougall, C. G.
Related Collections
Right arrow Restenosis
Right arrow Other arteriosclerosis
Right arrow Other Treatment
Right arrow Angioplasty and Stenting

(Stroke. 2009;40:106.)
© 2009 American Heart Association, Inc.


Original Contributions

Target Lesion Revascularization After Wingspan

Assessment of Safety and Durability

David J. Fiorella, MD, PhD; Elad I. Levy, MD; Aquilla S. Turk, DO; Felipe C. Albuquerque, MD; G. Lee Pride, Jr, MD; Henry H. Woo, MD; Babu G. Welch, MD; David B. Niemann, MD; Phillip D. Purdy, MD; Beverly Aagaard-Kienitz, MD; Peter A. Rasmussen, MD; L. Nelson Hopkins, MD; Thomas J. Masaryk, MD Cameron G. McDougall, MD

From Departments of Neurosurgery and Neuroradiology (D.J.F., P.A.R., T.J.M.), Cleveland Clinic Foundation, Cleveland, Ohio; Departments of Neurosurgery and Radiology and Toshiba Stroke Research Center (E.I.L., L.N.H.), School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Millard Fillmore Gates Hospital, Kaleida Health, Buffalo, NY; Departments of Radiology and Neurosurgery (A.S.T.), Medical University of South Carolina, Charleston, SC; Department of Neurosurgery (F.C.A., C.G.M.), Barrow Neurological Institute, Phoenix, Ariz; Departments of Neurosurgery and Neuroradiology (L.P., B.G.W., P.D.P.), University of Texas Southwestern, Dallas, Tex; Departments of Neurological Surgery and Radiology (H.H.W.), University at Stony Brook, State University of New York, Stony Brook, NY; Departments of Neurosurgery and Neuroradiology (D.N., B.A.-K.), University of Wisconsin, Madison, Wisc.

Correspondence to David J. Fiorella, MD, PhD, Barrow Neurosurgical Associates, Ltd, Phoenix–Main Office, 2910 N. 3rd Avenue, Phoenix, AZ 85013. E-mail david.fiorella{at}bnaneuro.net

Background and Purpose— In-stent restenosis (ISR) occurs in approximately one-third of patients after the percutaneous transluminal angioplasty and stenting of intracranial atherosclerotic lesions with the Wingspan system. We review our experience with target lesion revascularization (TLR) for ISR after Wingspan treatment.

Methods— Clinical and angiographic follow-up results were recorded for all patients from 5 participating institutions in our US Wingspan Registry. ISR was defined as >50% stenosis within or immediately adjacent (within 5 mm) to the implanted stent and >20% absolute luminal loss.

Results— To date, 36 patients in the registry have experienced ISR after percutaneous transluminal angioplasty and stenting with Wingspan. Of these patients, 29 (80.6%) have undergone TLR with either angioplasty alone (n=26) or angioplasty with restenting (n=3). Restenting was performed for in-stent dissections that occurred after the initial angioplasty. Of the 29 patients undergoing TLR, 9 required ≥1 interventions for recurrent ISR, for a total of 42 interventions. One major complication, a postprocedural reperfusion hemorrhage, was encountered in the periprocedural period (2.4% per procedure; 3.5% per patient). Angiographic follow-up is available for 22 of 29 patients after TLR. Eleven of 22 (50%) demonstrated recurrent ISR at follow-up angiography. Nine patients have undergone multiple retreatments (2 retreatments, n=6; 3 retreatments, n=2; 4 retreatments, n=1) for recurrent ISR. Nine of 11 recurrent ISR lesions were located within the anterior circulation. The mean age for patients with recurrent anterior circulation ISR was 57.9 years (vs 81 years for posterior circulation ISR).

Conclusions— TLR can be performed for the treatment of intracranial Wingspan ISR with a relatively high degree of safety. However, the TLR results are not durable in {approx}50% of patients, and multiple revascularization procedures may be required in this subgroup.


Key Words: intracranial atherosclerotic disease • poststenting in-stent restenosis • target lesion revascularization • Wingspan stent system




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
E.F. Hauck, J. Mocco, K.V. Snyder, and E.I. Levy
Temporary Endovascular Bypass: A Novel Treatment for Acute Stroke
AJNR Am. J. Neuroradiol., September 1, 2009; 30(8): 1532 - 1533.
[Abstract] [Full Text] [PDF]